Goncharova S A, Demidova N S, Shiriaeva O A, Shevtsova V N, Konovalova N P
Eksp Onkol. 1987;9(4):42-7.
Two strains of P388 murine leukemia with acquired resistance to rubomycin (P388/rm) and its nitroxyl derivative ruboxyl (P388/rx). The rubomycin resistance has been developed by the 14th generation and ruboxyl one-by the 8th generation. The growth kinetic patterns and the cell cycle time of the parent and resistant strains were similar. An increased tumourogenicity of both resistant strains cells was found. The resistance development was accompanied by the appearance of the additional chromosome materials, namely of homogeneously staining region (P388/rx) and of double chromatin bodies (P388/rm). The partial recovery of sensitivity to rubomycin occurred during 36 generations (1 year). Simultaneously the genetic markers have been lost. The recovery of sensitivity to ruboxyl in this period was not observed. The obtained resistant strains possessed the multidrug resistance: the cross resistance of P388/rm and P388/rx to actinomycin D, Vinca alkaloids and colchicine was shown.
两株对柔红霉素(P388/rm)及其硝酰衍生物鲁博克西(P388/rx)具有获得性耐药的P388小鼠白血病细胞系。柔红霉素耐药性在第14代时产生,鲁博克西耐药性在第8代时产生。亲本细胞系和耐药细胞系的生长动力学模式及细胞周期时间相似。发现两种耐药细胞系的致瘤性均增强。耐药性的产生伴随着额外染色体物质的出现,即均匀染色区(P388/rx)和双染色质体(P388/rm)。在36代(1年)期间,对柔红霉素的敏感性部分恢复。同时,遗传标记丢失。在此期间未观察到对鲁博克西敏感性的恢复。所获得的耐药细胞系具有多药耐药性:显示P388/rm和P388/rx对放线菌素D、长春花生物碱和秋水仙碱具有交叉耐药性。